Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report. [PDF]
CureusThis case report describes a 30-year-old male patient with extensively treatment-resistant alopecia universalis in the context of autoimmune and atopic comorbidities, including eczema, asthma, severe allergic reactions, and Hashimoto’s thyroiditis.
Bhardwaj S +4 more
europepmc +2 more sources
Haarwachstum unter Dupilumab bei Alopecia areata universalis und atopischer Dermatitis [PDF]
, 2021 We report the case of a 46-year-old woman who has suffered from severe atopic dermatitis since early childhood and from alopecia areata totalis since she was 18 years old, which has now developed into alopecia areata universalis.
Lindhof, H. +4 more
core +1 more source
Alopecia Universalis Associated with Cutaneous T Cell Lymphoma [PDF]
, 2014 Background: Alopecia areata-like hair loss may occur in the context of cutaneous T cell lymphoma (CTCL) and can very rarely evolve to alopecia universalis-like presentation.
Miteva, Mariya +6 more
core +1 more source
Treatment of alopecia areata partim universalis with efalizumab [PDF]
, 2006 Alopecia areata (AA) is considered an autoimmune disease targeted at hair follicles with T-lymphocytes playing an important role in the pathogenesis. Treatment of AA, particularly the totalis and universalis subtypes, is often difficult and remains a ...
Kaelin, Ursula +3 more
core +1 more source
Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth. [PDF]
, 2023 Alopecia universalis is alopecia areata (AA) with total-body involvement of hair loss. The disease progression is due to autoimmune T cells.
Schwartzberg, Lauren, DO, Spizuoco, Amy
core
Alopecia areata universalis elicited during treatment with adalimumab [PDF]
, 2008 Adalimumab is a fully humanized recombinant anti-tumour-necrosis-factor (TNF-alpha) monoclonal antibody which has been approved for rheumatoid arthritis, active ankylosing spondylitis, psoriatic arthritis and Crohn's disease. We report a case of alopecia
Braathen, Lasse R +4 more
core +1 more source
Attenuation of Autoimmune Phenomena in a Patient with Autoimmune Polyglandular Syndrome Type 1
Case Reports in Endocrinology, 2021 Autoimmune polyglandular syndrome type 1 (APS1) is a progressive life-threatening illness with no known cure. Current treatments involve replacement of the hormone deficiencies that result from autoimmune destruction of multiple endocrine organs.
Jill D. Jacobson +3 more
doaj +1 more source
Journal of the American Academy of Dermatology, 1993 as is usual in DDD, an increasednumber ofmelanocytes was not found in our patient, unlike the patient of Kameyama et aI. Kameyama and co-workers suggest that azelaic acid more easily penetrates active melanocytes; perhaps in our patient the melanocyteswere in a less active state.
Karla Werninghaus, Michael S. Kaminer
openaire +1 more source
Excellent response to tofacitinib treatment in a patient with alopecia universalis [PDF]
, 2017 Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the treatment options seldom provide satisfactory results.
Erduran, F. +9 more
core +1 more source
Supplemental Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta-analysis" [PDF]
, 2019 Supplemental Table 1 and Results for "Epidemiology of alopecia areata, ophiasis, totalis and universalis: A systematic review and meta ...
Silverberg, J
core +3 more sources